The European Investment Bank (EIB) has allocated €55 million in EU-guaranteed funding under the Ukraine Recovery Programme to rebuild critical so ...

Volkswagen celebrates 50 years of the Polo, an iconic small car that has sold over 20 million units across six generations since its debut in 1975.

(IN BRIEF) Volkswagen celebrates 50 years of the Polo, an iconic small car that has sold over 20 million units across six generations since its debut in 1975. Renowned for its affordability, quality, ...

The European Investment Bank (EIB) has allocated €55 million in EU-guaranteed funding under the Ukraine Recovery Programme to rebuild critical social infrastructure in 2025 and beyond. This funding, ...

(IN BRIEF) The European Investment Bank (EIB) has allocated €55 million in EU-guaranteed funding under the Ukraine Recovery Programme to rebuild critical social infrastructure in 2025 and beyond. This ...

The European Union's press release distribution & newswire service ...

(IN BRIEF) HOCHTIEF Group has been included in the prestigious Dow Jones Sustainability World and Europe Indices for the 19th consecutive year, recognizing its leadership in environmental, social, and ...

(IN BRIEF) Roche has announced results from the Phase IIb PADOVA study evaluating prasinezumab in 586 individuals with early-stage Parkinson’s disease. While the primary endpoint of time to confirmed ...

(IN BRIEF) BAE Systems’ PHASA-35, a solar-powered High Altitude Pseudo Satellite (HAPS), has successfully completed a series of test flights at Spaceport America, New Mexico, reaching altitudes of ...

(IN BRIEF) Thales has introduced an advanced vehicle access solution combining digital car keys with the newly launched NFC CARd Key, designed to enhance convenience and security in the automotive ...

(IN BRIEF) BASF, alongside partners Endress+Hauser, TechnoCompound, and the Universities of Bayreuth and Jena, is leading the SpecReK project to enhance the mechanical recycling of plastics using ...

(IN BRIEF) Roche has announced results from the Phase IIb PADOVA study evaluating prasinezumab in 586 individuals with early-stage Parkinson’s disease. While the primary endpoint of time to confirmed ...